The Global Benzathine Penicillin G Market size was valued at USD 1.50 Bn. in 2024, and the total Global Benzathine Penicillin G Market revenue is expected to grow by 7.5% from 2024 to 2032, reaching nearly USD 2.68 Bn.Global Benzathine Penicillin G Market Overview
Benzathine Penicillin G is an antibiotic used for the treatment of various bacterial infections such as bejel and diphtheria. Its use is growing for treating the sexually transmitted disease of syphilis. It inhibits bacterial cell wall synthesis. The Benzathine Penicillin G market is continuing to grow steadily, primarily because of the increased rates of syphilis and other types of bacterial infections in low- and middle-income regions such as Africa, Southeast Asia, and Latin America. In addition, global health measures from the WHO or national health ministries are encouraging greater benzathine penicillin G use in some treatment protocols. Bejel (endemic syphilis) was part of endemic treponematoses such as pinta and yaws. The global burden was reduced drastically from 50 million cases to 2.5 million through mass penicillin campaigns.To know about the Research Methodology :- Request Free Sample Report North America held the dominant share of the global Benzathine Penicillin G market in 2024, supported by its pharmaceutical infrastructure, disease surveillance systems and government-supported antibiotic stewardship policies, which are contributing to a well-documented case volume. Europe maintains a stable market share, underpinned by its historically established healthcare systems. Asia-Pacific and Africa are driven by improved access to antibiotics through donors' support and the rising healthcare needs of patients. The market features major manufacturers including Pfizer Inc. (USA), Novartis AG (Switzerland), and Aurobindo Pharma Ltd. (India), who are ramping up production or leveraging partnerships to support regional salability for global supply.
Global Benzathine Penicillin G Market Dynamics
Rising Global Disease Burden and Public Health Initiatives to Drive Benzathine Penicillin G Market The rising incidence of bacterial infections, including syphilis, rheumatic fever, and diphtheria and Increased awareness of antibiotic treatments continue to support the Benzathine Penicillin G Market growth. The WHO identifies Benzathine Penicillin G as a first-line treatment for syphilis and prophylactic treatment of rheumatic fever. Numerous national health programs in Africa, Southeast Asia, and Latin America recommend long-acting penicillin. The drug’s low cost, high efficacy, and long-acting formulation make it suitable for low-resource settings. Additionally, continued procurement by organizations such as the UN and PAHO supports a global distribution framework that sustains demand and improves access. Supply Chain Limitations and Manufacturing Challenges to Restrain the Benzathine Penicillin G Market Supply instability stems from reliance on a limited number of global manufacturers. Limited producers, raw material constraints, and complex manufacturing make the supply vulnerable. The main challenge is not only supply instability, but also maintaining the continuity of treatment. There are additional challenges in establishing stability across regional markets because of regulatory restrictions that are related to injectable, antibiotic manufacturing, and distribution. These challenges are exacerbated by a cold chain required to store and ship Benzathine Penicillin G, which is expensive and limits facilities in using this treatment in remote areas or rural communities. Growing Investment in Antibiotic Stewardship and Partnerships to Create Opportunities in Benzathine Penicillin G Market Growing awareness of public–private partnerships, government procurement programs, and global disease elimination initiatives is creating new market opportunities. Collaborations between NGOs, pharmaceutical companies, and public health agencies are enhancing access and enabling local manufacturing. The potential lies in R&D for extended-release formulations and combination therapies, benefiting the developed and developing Benzathine Penicillin G Market. The increasing investments in supply chain resilience and localized production facilities are expected to strengthen the availability of benzathine penicillin G, particularly in regions facing recurrent shortages. Strategic alliances with contract manufacturing organizations (CMOs) and technology transfer agreements are enabling faster regulatory approvals and improved quality compliance. These efforts, coupled with digital health platforms for demand forecasting and distribution optimization, help for the Benzathine Penicillin G Market footprint and ensure sustainable access to this essential antibiotic across diverse healthcare settings.Global Benzathine Penicillin G Market Segment Analysis
Based on Application The Global Benzathine Penicillin G Market has been subdivided into Bacterial Infections, Bejel, Diphtheria, Rheumatic Fever, and Syphilis. Syphilis held the highest Benzathine Penicillin G share in the market in 2024 and is expected to continue dominating during the forecast period. The shifting prevalence towards the rising global incidence of sexually transmitted infections (STIs), particularly that of syphilis, continues to challenge and support the need to use Benzathine Penicillin in the treatment of syphilis. It remains the cornerstone treatment of syphilis since it is an effective and inexpensive antibiotic, and the WHO indicates that the steadily increasing incidence of syphilis is already concerning. Furthermore, the majority of efforts to curb the incidence of congenital syphilis and the increasing syphilis screening among pregnant women add to the overall demand. The use of Benzathine Penicillin G for rheumatic fever prevention remains a relevant subject and prevalent in areas where rheumatic fever is endemic, in greater sub-Saharan Africa and Southeast Asia it is still regarded as a public health problem.Global Benzathine Penicillin G Market Regional Insights
North America has a significant share of the global Benzathine Penicillin G market due to a high level of pharmaceutical manufacturing capability, regulatory expectations, and a well-developed healthcare system. The US, in particular, is important because of the widespread use of Benzathine Penicillin G for the clinical treatment of syphilis, rheumatic heart disease (RHD), and the large amount of long-term procurement contracts granted by the CDC and other Community Health Service Agencies. In North America, particularly in the United States, syphilis prevalence has been a significant public health concern, directly influencing the demand for Benzathine Penicillin G. In 2023, there were approximately 209,253 reported syphilis cases, of which 53,007 were classified as primary and secondary (P&S) syphilis, the most infectious stages of the disease. This equates to an overall P&S syphilis rate of around 16 cases per 100,000 people, with disproportionately higher rates among certain demographics. Males aged 30–34 experienced rates of about 62 cases per 100,000. Congenital syphilis has also been rising sharply, with 3,882 cases reported in 2023, including 279 stillbirths or infant deaths, translating to 105.8 cases per 100,000 live births, a 3% increase from 2022. While primary and secondary syphilis rates declined by 10% in 2023, the first such drop in over two decades, late-stage and congenital syphilis cases continued to increase, underscoring persistent transmission and treatment challenges. Government FundingGlobal Benzathine Penicillin G Market Competitive Landscape Pfizer consistently commands its Benzathine Penicillin G Market position using a fully vertically integrated supply chain, WHO-prequalified facilities, and long-term procurement contracts with U.S. federal agencies, including the Centers for Disease Control and Prevention (CDC). Aurobindo Pharma is building its global distribution network and brand by using its lower-cost production capabilities to win public health tenders in African countries, Southeast Asia, and Latin America. Using its expertise in injectable formulations, reimbursement background, and even investing in the development of substantial production facilities compliant with the health and safety features of GMP, it is a future supplier for public health systems in countries where preventive medication is more cost-effective than managing advanced illness.
Government Initiative Funding Focus Area WHO / PAHO (Global) Elimination of Congenital Syphilis Program USD 1.4 Bn Drug procurement, maternal screening, and STI control India – Ministry of Health National Vector Borne Disease Control Program USD 0.8 Bn Free supply of injectable antibiotics in public hospitals Africa CDC / GAVI Alliance Maternal and Child Health Strategy USD 0.6 Bn Benzathine Penicillin procurement for public immunization initiatives Global Benzathine Penicillin G Market Trends
Category Market Trend Impact Manufacturing Expansion Strengthening domestic API capabilities Enhances supply security and meets long-term contract demands Regional Access Localization of antibiotic distribution Improves last-mile delivery and reduces import dependency in Africa Sustainable Production Eco-friendly antibiotic manufacturing Aligns with ESG goals; reduces environmental impact Formulation Innovation Development of heat-stable injectable drugs Enables better storage in LMICs lacking cold-chain logistics Benzathine Penicillin G Market Scope: Inquire before buying
Global Benzathine Penicillin G Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 1.50 Bn. Forecast Period 2025 to 2032 CAGR: 7.5% Market Size in 2032: USD 2.68 Bn. Segments Covered: by Application Bacterial Infection Bejel Diphtheria Rheumatic Fever Syphilis Others by Mode of Ijection Intravenous Injection Intramuscular Injection by End User Hospitals and Clinics Ambulatory Surgical Centers Diagnostics Centers Research Centers Others Global Benzathine Penicillin G Market, by Region
North America (United States, Canada, Mexico) Europe (United Kingdom, France, Germany, Italy, Spain, Sweden, Russia, Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam, Rest of Asia Pacific) Middle East and Africa (MEA) (South Africa, GCC, Nigeria, Rest of MEA) South America (Brazil, Argentina, Colombia, Chile, Rest of South America)Global Benzathine Penicillin G Market, Key Players
North America 1. Pfizer Inc. (USA) 2. Sanofi S.A. (France) 3. Merck & Co., Inc. (USA) 4. Cardinal Health (USA) Europe 1. GlaxoSmithKline Plc (UK) 2. Novartis AG (Switzerland) 3. Roche Holding AG (Switzerland) 4. Bayer AG (Germany) 5. Chemopharma GmbH (Vienna, Austria) 6. Fresenius Kabi AB Brunna (Bad Homburg, Germany) Asia-Pacific 1. Aurobindo Pharma Ltd. (India) 2. Cipla Ltd. (India) 3. CSPC Pharmaceutical Group (China) 4. Alembic Pharma (India) 5. Teva Pharmaceutical Industries Ltd. (Israel) 6. Mylan N.V. (USA/India)Frequently Asked Questions
1. Which region has the largest share in the Global Benzathine Penicillin G Market? Ans: North America held the highest Benzathine Penicillin G Market share in 2024. 2. What is the growth rate of the Global Benzathine Penicillin G Market? Ans: The Global Benzathine Penicillin G Market is expected to grow at a CAGR of 7.5% during the forecast period 2025-2032. 3. What is the scope of the Global Benzathine Penicillin G Market report? Ans: The Global Benzathine Penicillin G Market report helps with the PESTEL, Porter's, Recommendations for Investors and leaders, and market estimation for the forecast period. 4. Who are the key players in the Global Benzathine Penicillin G Market? Ans: The important key players in the Global Benzathine Penicillin G Market are Pfizer Inc. (USA), Sanofi S.A. (France), Merck & Co., Inc. (USA), Aurobindo Pharma Ltd. (India), Cipla Ltd. (India), and CSPC Pharmaceutical Group (China). 5. What is the study period of this market? Ans: The market is analyzed for the period 2025–2032, with historical data from 2019 to 2024.
1. Benzathine Penicillin G Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Benzathine Penicillin G Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Benzathine Penicillin G Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Benzathine Penicillin G Market: Dynamics 3.1. Benzathine Penicillin G Market Trends by Region 3.1.1. North America Benzathine Penicillin G Market Trends 3.1.2. Europe Benzathine Penicillin G Market Trends 3.1.3. Asia Pacific Benzathine Penicillin G Market Trends 3.1.4. Middle East and Africa Benzathine Penicillin G Market Trends 3.1.5. South America Benzathine Penicillin G Market Trends 3.2. Benzathine Penicillin G Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Benzathine Penicillin G Market Drivers 3.2.1.2. North America Benzathine Penicillin G Market Restraints 3.2.1.3. North America Benzathine Penicillin G Market Opportunities 3.2.1.4. North America Benzathine Penicillin G Market Challenges 3.2.2. Europe 3.2.2.1. Europe Benzathine Penicillin G Market Drivers 3.2.2.2. Europe Benzathine Penicillin G Market Restraints 3.2.2.3. Europe Benzathine Penicillin G Market Opportunities 3.2.2.4. Europe Benzathine Penicillin G Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Benzathine Penicillin G Market Drivers 3.2.3.2. Asia Pacific Benzathine Penicillin G Market Restraints 3.2.3.3. Asia Pacific Benzathine Penicillin G Market Opportunities 3.2.3.4. Asia Pacific Benzathine Penicillin G Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Benzathine Penicillin G Market Drivers 3.2.4.2. Middle East and Africa Benzathine Penicillin G Market Restraints 3.2.4.3. Middle East and Africa Benzathine Penicillin G Market Opportunities 3.2.4.4. Middle East and Africa Benzathine Penicillin G Market Challenges 3.2.5. South America 3.2.5.1. South America Benzathine Penicillin G Market Drivers 3.2.5.2. South America Benzathine Penicillin G Market Restraints 3.2.5.3. South America Benzathine Penicillin G Market Opportunities 3.2.5.4. South America Benzathine Penicillin G Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Benzathine Penicillin G Industry 3.8. Analysis of Government Schemes and Initiatives For Benzathine Penicillin G Industry 3.9. Benzathine Penicillin G Market Trade Analysis 3.10. The Global Pandemic Impact on Benzathine Penicillin G Market 4. Benzathine Penicillin G Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 4.1.1. Bacterial Infection 4.1.2. Bejel 4.1.3. Diphtheria 4.1.4. Rheumatic Fever 4.1.5. Syphilis 4.1.6. Others 4.2. Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 4.2.1. Intravenous Injection 4.2.2. Intramuscular Injection 4.3. Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 4.3.1. Hospitals and Clinics 4.3.2. Ambulatory Surgical Centers 4.3.3. Diagnostics Centers 4.3.4. Research Centers 4.3.5. Others 4.4. Benzathine Penicillin G Market Size and Forecast, by Region (2024-2032) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Benzathine Penicillin G Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 5.1.1. Bacterial Infection 5.1.2. Bejel 5.1.3. Diphtheria 5.1.4. Rheumatic Fever 5.1.5. Syphilis 5.1.6. Others 5.2. North America Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 5.2.1. Intravenous Injection 5.2.2. Intramuscular Injection 5.3. North America Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 5.3.1. Hospitals and Clinics 5.3.2. Ambulatory Surgical Centers 5.3.3. Diagnostics Centers 5.3.4. Research Centers 5.3.5. Others 5.4. North America Benzathine Penicillin G Market Size and Forecast, by Country (2024-2032) 5.4.1. United States 5.4.1.1. United States Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 5.4.1.1.1. Bacterial Infection 5.4.1.1.2. Bejel 5.4.1.1.3. Diphtheria 5.4.1.1.4. Rheumatic Fever 5.4.1.1.5. Syphilis 5.4.1.1.6. Others 5.4.1.2. United States Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 5.4.1.2.1. Intravenous Injection 5.4.1.2.2. Intramuscular Injection 5.4.1.3. United States Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 5.4.1.3.1. Hospitals and Clinics 5.4.1.3.2. Ambulatory Surgical Centers 5.4.1.3.3. Diagnostics Centers 5.4.1.3.4. Research Centers 5.4.1.3.5. Others 5.4.2. Canada 5.4.2.1. Canada Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 5.4.2.1.1. Bacterial Infection 5.4.2.1.2. Bejel 5.4.2.1.3. Diphtheria 5.4.2.1.4. Rheumatic Fever 5.4.2.1.5. Syphilis 5.4.2.1.6. Others 5.4.2.2. Canada Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 5.4.2.2.1. Intravenous Injection 5.4.2.2.2. Intramuscular Injection 5.4.2.3. Canada Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 5.4.2.3.1. Hospitals and Clinics 5.4.2.3.2. Ambulatory Surgical Centers 5.4.2.3.3. Diagnostics Centers 5.4.2.3.4. Research Centers 5.4.2.3.5. Others 5.4.3. Mexico 5.4.3.1. Mexico Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 5.4.3.1.1. Bacterial Infection 5.4.3.1.2. Bejel 5.4.3.1.3. Diphtheria 5.4.3.1.4. Rheumatic Fever 5.4.3.1.5. Syphilis 5.4.3.1.6. Others 5.4.3.2. Mexico Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 5.4.3.2.1. Intravenous Injection 5.4.3.2.2. Intramuscular Injection 5.4.3.3. Mexico Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 5.4.3.3.1. Hospitals and Clinics 5.4.3.3.2. Ambulatory Surgical Centers 5.4.3.3.3. Diagnostics Centers 5.4.3.3.4. Research Centers 5.4.3.3.5. Others 6. Europe Benzathine Penicillin G Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.2. Europe Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.3. Europe Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 6.4. Europe Benzathine Penicillin G Market Size and Forecast, by Country (2024-2032) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.4.1.2. United Kingdom Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.4.1.3. United Kingdom Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 6.4.2. France 6.4.2.1. France Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.4.2.2. France Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.4.2.3. France Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 6.4.3. Germany 6.4.3.1. Germany Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.4.3.2. Germany Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.4.3.3. Germany Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 6.4.4. Italy 6.4.4.1. Italy Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.4.4.2. Italy Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.4.4.3. Italy Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 6.4.5. Spain 6.4.5.1. Spain Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.4.5.2. Spain Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.4.5.3. Spain Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 6.4.6. Sweden 6.4.6.1. Sweden Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.4.6.2. Sweden Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.4.6.3. Sweden Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 6.4.7. Austria 6.4.7.1. Austria Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.4.7.2. Austria Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.4.7.3. Austria Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 6.4.8.2. Rest of Europe Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 6.4.8.3. Rest of Europe Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7. Asia Pacific Benzathine Penicillin G Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.2. Asia Pacific Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.3. Asia Pacific Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4. Asia Pacific Benzathine Penicillin G Market Size and Forecast, by Country (2024-2032) 7.4.1. China 7.4.1.1. China Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.1.2. China Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.1.3. China Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.2. S Korea 7.4.2.1. S Korea Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.2.2. S Korea Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.2.3. S Korea Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.3. Japan 7.4.3.1. Japan Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.3.2. Japan Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.3.3. Japan Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.4. India 7.4.4.1. India Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.4.2. India Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.4.3. India Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.5. Australia 7.4.5.1. Australia Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.5.2. Australia Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.5.3. Australia Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.6. Indonesia 7.4.6.1. Indonesia Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.6.2. Indonesia Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.6.3. Indonesia Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.7. Malaysia 7.4.7.1. Malaysia Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.7.2. Malaysia Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.7.3. Malaysia Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.8. Vietnam 7.4.8.1. Vietnam Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.8.2. Vietnam Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.8.3. Vietnam Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.9. Taiwan 7.4.9.1. Taiwan Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.9.2. Taiwan Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.9.3. Taiwan Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 7.4.10.2. Rest of Asia Pacific Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 7.4.10.3. Rest of Asia Pacific Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 8. Middle East and Africa Benzathine Penicillin G Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 8.2. Middle East and Africa Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 8.3. Middle East and Africa Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 8.4. Middle East and Africa Benzathine Penicillin G Market Size and Forecast, by Country (2024-2032) 8.4.1. South Africa 8.4.1.1. South Africa Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 8.4.1.2. South Africa Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 8.4.1.3. South Africa Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 8.4.2. GCC 8.4.2.1. GCC Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 8.4.2.2. GCC Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 8.4.2.3. GCC Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 8.4.3. Nigeria 8.4.3.1. Nigeria Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 8.4.3.2. Nigeria Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 8.4.3.3. Nigeria Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 8.4.4.2. Rest of ME&A Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 8.4.4.3. Rest of ME&A Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 9. South America Benzathine Penicillin G Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 9.2. South America Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 9.3. South America Benzathine Penicillin G Market Size and Forecast, by End user(2024-2032) 9.4. South America Benzathine Penicillin G Market Size and Forecast, by Country (2024-2032) 9.4.1. Brazil 9.4.1.1. Brazil Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 9.4.1.2. Brazil Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 9.4.1.3. Brazil Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 9.4.2. Argentina 9.4.2.1. Argentina Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 9.4.2.2. Argentina Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 9.4.2.3. Argentina Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Benzathine Penicillin G Market Size and Forecast, by Application (2024-2032) 9.4.3.2. Rest Of South America Benzathine Penicillin G Market Size and Forecast, by Mode of Injection (2024-2032) 9.4.3.3. Rest Of South America Benzathine Penicillin G Market Size and Forecast, by End user (2024-2032) 10. Company Profile: Key Players 10.1. Pfizer Inc. (USA) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Sanofi S.A. (France) 10.3. Merck & Co., Inc. (USA) 10.4. Cardinal Health (USA) 10.5. GlaxoSmithKline Plc (UK) 10.6. Novartis AG (Switzerland) 10.7. Roche Holding AG (Switzerland) 10.8. Bayer AG (Germany) 10.9. Chemopharma GmbH (Vienna, Austria) 10.10. Fresenius Kabi AB Brunna (Bad Homburg, Germany) 10.11. Aurobindo Pharma Ltd. (India) 10.12. Cipla Ltd. (India) 10.13. CSPC Pharmaceutical Group (China) 10.14. Alembic Pharma (India) 10.15. Teva Pharmaceutical Industries Ltd. (Israel) 10.16. Mylan N.V. (USA/India) 11. Key Findings 12. Industry Recommendations 13. Benzathine Penicillin G Market: Research Methodology 14. Terms and Glossary
